封面
市场调查报告书
商品编码
1542931

全球远端监控穿戴式装置市场 - 2024-2031

Global Remote Monitoring Wearables Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年,全球远端监控穿戴式装置市场规模达54亿美元,预计到2031年将达到151亿美元,2024-2031年预测期间复合年增长率为14.1%。

远端监控穿戴式装置功能是一种技术小工具,旨在收集用户提供的健康资料并将其发送给个人健康应用程式或医疗保健从业者。这些小工具可以连续追踪众多生理参数,帮助使用者采取健康预防措施。

穿戴式装置可以透过蓝牙或 Wi-Fi 连接到智慧型手机或云,与医疗保健从业者或健康应用程式共享即时资料。用于远端患者监测的可穿戴设备可以轻鬆地与远距医疗平台集成,使医疗专业人员能够远端观察患者并即时修改治疗方案。

市场动态:

驱动程式和限制

慢性病盛行率增加

慢性病盛行率的上升预计将推动市场成长。为了正确管理症状,糖尿病、高血压和心血管问题等慢性疾病需要持续的健康监测。具有远端监控功能的可穿戴设备使患者能够即时追踪他们的健康状况和生命体征,从而改善对他们病情的管理。

慢性病的盛行率正在增加,预计这将增加医疗保健提供者管理患者健康状况和症状的能力。

例如,2023 年 6 月,华盛顿大学健康指标与评估研究所表示,全球有超过 5 亿人患有糖尿病,影响每个国家各个年龄层的男性、女性和儿童,而这个数字预计未来30 年人口将增加一倍以上,达到13 亿。

透过让患者和医疗专业人员能够存取最新资料,穿戴式装置有助于主动处理慢性病。这使得可以及早发现可能的问题,从而及时采取行动并减少入院人数。

老年人缺乏对科技的采用

许多潜在用户,尤其是老年人,可能会面临对科技和智慧产品不熟悉的问题。这种不适感可能会阻碍穿戴式科技的采用,从而降低其监测健康的能力。用于远端监控的可穿戴设备可能会导致用户怀疑其功效和精确度。如果使用者没有看到这些设备对他们的健康结果有明显的好处或改善,他们可能会犹豫是否要采用这些设备。

细分市场分析

全球远端监控穿戴式装置市场根据装置类型、疾病、功能、最终用户和地区进行细分。

智慧手錶和健身追踪器领域预计将主导市场份额

智慧手錶和健身追踪器领域预计将在市场份额中占据主要地位。近年来,健身追踪器和智慧手錶不断扩展。这些优雅的腕戴式小工具具有多种功能和感应器,可让使用者专注于各种健康指标。

为了监测心率、睡眠模式、压力水平和日常身体活动,医生经常推荐智慧手錶和健身追踪器。此外,其中一些设备具有心电图监测等功能,可用于识别可能的心臟问题和心律异常。

技术的不断进步以及患者和医疗保健提供者使用舒适的公司越来越多的先进设备预计将推动该细分市场的成长。

例如,2024 年7 月,物联网(IoT) 公司KORE 宣布推出一款用于虚拟病患监护的智慧手錶,名为mCareWatch 241。追踪、提醒、心率监测器、快速拨号、跌倒侦测、计步器、地理围栏警报、非运动侦测以及行动应用程式和网路仪表板。

此外,2024 年 7 月 12 日,三星推出了其扩展的可穿戴产品系列,包括备受关注的新款 Galaxy Ring,它可以与智慧型手机和智慧手錶进行端到端集成,24/7 全天候佩戴。这款轻巧的设备拥有一套感测器,可连续监测关键的健康指标,包括睡眠模式、心率变异性和全天 24 小时的活动水平。

市场地理分析

预计北美将在远端监控穿戴式装置市场份额中占据重要地位

北美在市场占有率中占有重要地位。技术进步不断进步,慢性病盛行率不断上升,个人意识不断增强。该地区大量设备製造商的存在也有望使该地区在市场份额上占据主导地位。

例如,2023 年 6 月,STAT Health 推出了一款 24/7 入耳式穿戴式一般健康产品,可测量头部的血流量,以便更好地了解站立时发生的身体状况。

此外,2022 年 11 月,远距復健远端患者监测穿戴式解决方案开发商 Sensoria Health 推出了第一个真正的穿戴式远距復健平台。 Sensoria 提供以患者为中心的多设备行动和云端软体远端復健系统,使物理治疗师和临床医生能够轻鬆有效地远端监控患者群体中最常见的状况。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 慢性病盛行率增加
    • 限制
      • 老年人缺乏对科技的采用
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 报销分析
  • 专利分析
  • SWOT分析
  • DMI 意见

第 6 章:按装置类型

  • 智慧手錶和健身追踪器
  • 连续血糖监测仪 (CGM)
  • 穿戴式心电图监视器
  • 远端监控补丁
  • 其他的

第 7 章:依疾病分类

  • 心血管疾病
  • 气喘
  • 阿兹海默症
  • 肾臟疾病
  • 其他的

第 8 章:按功能

  • 心率追踪
  • ECG(心电图)
  • 血氧浓度 (SpO2) 监测
  • 睡眠品质监测
  • 身体活动监测
  • 其他的

第 9 章:最终用户

  • 医院
  • 诊所
  • 其他的

第 10 章:按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • MedIoTek Health Systems
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • BioIntelliSense, Inc.
  • Apple Inc.
  • AliveCor India
  • Koninklijke Philips NV,
  • Garmin Ltd.
  • Samsung Health
  • Biobeat
  • Qardio, Inc.
  • Fitbit (*LIST NOT EXHAUSTIVE)

第 13 章:附录

简介目录
Product Code: MD8602

Report Overview

Global Remote Monitoring Wearables Market reached US$ 5.4 billion in 2023 and is expected to reach US$ 15.1 billion by 2031, growing at a CAGR of 14.1% during the forecast period 2024-2031.

Remote monitoring wearables capabilities are technological gadgets designed to gather and send user-provided health data to personal health applications or healthcare practitioners. These gadgets provide the continuous tracking of numerous physiological parameters, assisting users in taking preventative measures for their health.

Wearables can share real-time data with healthcare practitioners or health apps by connecting to smartphones or the cloud via Bluetooth or Wi-Fi. Wearables for remote patient monitoring can easily be integrated with telehealth platforms, giving medical professionals the ability to watch patients from a distance and modify treatment regimens in real-time.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is expected to drive the market growth. To properly manage symptoms, chronic disorders like diabetes, hypertension, and cardiovascular issues require continual health monitoring. Wearables with remote monitoring allow patients to track their health measures and vital signs in real time, improving the management of their conditions.

The prevalence of chronic diseases is increasing, this is expected to increase healthcare providers to manage their patient's health conditions and manage their symptoms.

For instance, in June 2023, the Institute for Health Metrics and Evaluation of the University of Washington stated that more than half a billion people are living with diabetes worldwide, affecting men, women, and children of all ages in every country, and that number is projected to more than double to 1.3 billion people in the next 30 years.

By giving patients and medical professionals access to up-to-date data, wearables facilitate the proactive handling of chronic diseases. This makes it possible to detect possible problems at an early stage, allowing timely action and lowering the number of hospital admissions.

Lack of adoption of technology by elderly people

The lack of familiarity with technology and smart gadgets may be faced by many potential users, elderly people in particular. Wearable technology adoption can be hampered by this discomfort, which would reduce its ability to monitor health. Wearables for remote monitoring can lead users to doubt their efficacy and precision. Users may be hesitant to adopt these gadgets if they don't see an obvious benefit or improvement in their health results.

Market Segment Analysis

The global remote monitoring wearables market is segmented based on device type, disease, function, end-user, and region.

The smartwatches and fitness trackers segment is expected to dominate the market share

The smartwatches and fitness trackers segment is expected to hold a major position in the market share. In recent years, fitness trackers and smartwatches have expanded. These elegant, wrist-worn gadgets are featured with functions and sensors that let users keep an eye on a variety of health indicators.

For monitoring heart rate, sleep patterns, stress levels, and everyday physical activity, doctors frequently recommend smartwatches and fitness trackers. Additionally, some of these devices have abilities like ECG monitoring, which can be used to identify possible cardiac problems and abnormal heart rhythms.

The rising advancements in technology and an increasing number of advanced devices by the companies that are comfortable to use by the patients and healthcare providers are expected to drive the segment growth.

For instance, in July 2024, KORE, an Internet of Things (IoT) company announced the launch of a smartwatch for virtual patient monitoring called mCareWatch 241. The watch features an SOS setting that enables wearers to obtain emergency assistance, call capabilities, GPS tracking, reminders, a heart rate monitor, speed dialing, fall detection, a pedometer, a geo-fence alarm, non-movement detection, and a mobile app and web dashboard.

Additionally, on July 12, 2024, Samsung unveiled its expanded slate of wearable products, including the highly-buzzed new Galaxy Ring that can be worn 24/7 with end-to-end integration with its smartphones and smartwatches. The lightweight device boasts a suite of sensors that continuously monitor key health metrics including sleep patterns, heart rate variability, and activity levels 24 hours a day.

Market Geographical Analysis

North America is expected to hold a significant position in the remote monitoring wearables market share

North America holds a significant position in the market share. The rising technological advancements, increasing prevalence of chronic diseases, and increasing awareness among individuals. The presence of a large number of device manufacturers in the region is also expected to hold the region in a dominant position in the market share.

For instance, in June 2023, STAT Health introduced a 24/7 in-ear wearable general wellness product that measures blood flow to the head to allow a better understanding of conditions in the body that occur upon standing.

Additionally, in November 2022, Sensoria Health, a developer of tele-rehab remote patient monitoring wearable solutions, introduced the first truly wearable telerehabilitation platform. Sensoria offers a patient-centric, multi-device mobile and cloud software tele-rehab system that makes it easy and efficient for physical therapists and clinicians to remotely monitor the most common conditions in their patient population.

Market Segmentation

By Device Type

  • Smartwatches and Fitness Trackers
  • Continuous Glucose Monitors (CGMs)
  • Wearable ECG Monitors
  • Remote Monitoring Patches
  • Others

By Disease

  • Cardiovascular Diseases
  • Asthma
  • Alzheimer Disease
  • Kidney Diseases
  • Others

By Function

  • Heart Rate Tracking
  • ECG (Electrocardiogram)
  • Blood Oxygen Levels (SpO2) Monitoring
  • Sleep Quality Monitoring
  • Physical Activity Monitoring
  • Others

By End-User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Market Competitive Landscape

The major global players in the market include MedIoTek Health Systems, BioIntelliSense, Inc., Apple Inc., AliveCor India, Koninklijke Philips N.V., Garmin Ltd., Samsung Health, Biobeat, Qardio, Inc., and Fitbit among others.

Why Purchase the Report?

  • To visualize the global remote monitoring wearables market segmentation based on device type, disease, function, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of remote monitoring wearables market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global remote monitoring wearables market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Disease
  • 3.3. Snippet by Function
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of chronic diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of adoption of technology by elderly people
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. Smartwatches and Fitness Trackers *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Continuous Glucose Monitors (CGMs)
  • 6.4. Wearable ECG Monitors
  • 6.5. Remote Monitoring Patches
  • 6.6. Others

7. By Disease

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
    • 7.1.2. Market Attractiveness Index, By Disease
  • 7.2. Cardiovascular Diseases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Asthma
  • 7.4. Alzheimer Disease
  • 7.5. Kidney Diseases
  • 7.6. Others

8. By Function

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 8.1.2. Market Attractiveness Index, By Function
  • 8.2. Heart Rate Tracking *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. ECG (Electrocardiogram)
  • 8.4. Blood Oxygen Levels (SpO2) Monitoring
  • 8.5. Sleep Quality Monitoring
  • 8.6. Physical Activity Monitoring
  • 8.7. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.4.1. Germany
      • 10.3.4.2. UK
      • 10.3.4.3. France
      • 10.3.4.4. Italy
      • 10.3.4.5. Spain
      • 10.3.4.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.4.1. Brazil
      • 10.4.4.2. Argentina
      • 10.4.4.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.4.1. China
      • 10.5.4.2. India
      • 10.5.4.3. Japan
      • 10.5.4.4. South Korea
      • 10.5.4.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
  • 10.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. MedIoTek Health Systems*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. BioIntelliSense, Inc.
  • 12.3. Apple Inc.
  • 12.4. AliveCor India
  • 12.5. Koninklijke Philips N.V.,
  • 12.6. Garmin Ltd.
  • 12.7. Samsung Health
  • 12.8. Biobeat
  • 12.9. Qardio, Inc.
  • 12.10. Fitbit (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us